Inhibitors of AChE and BChE have found application as drugs developed for the treatment of Alzheimer’s disease which is a neurodegenerative disorder characterized by the loss of memory and consciousness. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.